Tacrolimus: A new topical immunomodulatory therapy for atopic dermatitis
- 31 March 2001
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 107 (3), 445-448
- https://doi.org/10.1067/mai.2001.113521
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitisJournal of Allergy and Clinical Immunology, 2001
- Evidence for a disease-promoting effect of Staphylococcus aureus–derived exotoxins in atopic dermatitisJournal of Allergy and Clinical Immunology, 2000
- Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitisJournal of Allergy and Clinical Immunology, 1999
- A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in childrenJournal of Allergy and Clinical Immunology, 1998
- Tacrolimus Ointment does not Affect Collagen Synthesis: Results of a Single-Center Randomized TrialJournal of Investigative Dermatology, 1998
- A Short-Term Trial of Tacrolimus Ointment for Atopic DermatitisNew England Journal of Medicine, 1997
- Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: An immunocytochemical studyJournal of Allergy and Clinical Immunology, 1996
- Immunomorphological and Ultrastructural Characterization of Langerhans Cells and a Novel, Inflammatory Dendritic Epidermal Cell (IDEC) Population in Lesional Skin of Atopic EczemaJournal of Investigative Dermatology, 1996
- Tacrolimus ointment for atopic dermatitisThe Lancet, 1994
- Anti-Inflammatory Effect of FK-506 on Human Skin Mast CellsJournal of Investigative Dermatology, 1992